Top Stock Picks for the Day: Radius Health, Inc. (RDUS), Viper Energy Partners LP (VNOM)

Radius Health, Inc. (NASDAQ:RDUS) shares were trading higher by 1.51 percent ($0.63) at $42.46 a piece in Wednesday’s session. It had closed the previous session at $41.83. RDUS trades with a P/S ratio of 0. This is lower than the both industry’s 96.41 and the wider sector’s 5.29. A low price-to-sales ratio, typically less than 1.0, is considered a good value. Also, it has an estimated price-earnings (P/E) multiple of 0 and a trailing 12-month price-earnings (P/E) multiple of 0. Shares of RDUS have uptrended 12.54% in the past three months. Radius Health, Inc. (RDUS) has a market cap of $1.88 billion and over the last 12 months, Radius Health, Inc. (NASDAQ:RDUS) has gone stronger by 8.79%. During the last 52 weeks, the (NASDAQ:RDUS) price has been as high as $59.88 and as low as $31.58. Radius Health, Inc. earnings have declined with an annualized rate of 0% over the last 5 years.

Radius Health, Inc. (Mean Target Price: $58.86)

The average 1-year price target for Radius Health, Inc. (RDUS) — averaging the work of different analysts — reveals a mean PT of $58.86/share. That’s a potential 38.62 increase relative to where Radius Health, Inc. (NASDAQ:RDUS) has been trading recently. The current price is seen ranging between $41.1 and $43.03. There are brokerage firms with lower targets than the average, including one setting a price target of $24. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $85.

Radius Health, Inc. (RDUS) Consensus Recommendation

The collective rating of 2.3 for Radius Health, Inc. (NASDAQ:RDUS) also leans strongly towards the neutral end of the spectrum. Of the 8 analysts surveyed by Reuters that track RDUS 2 of them rate its stock a hold. The other 6, though not evenly; between analysts who think you should buy Radius Health, Inc. versus those who think you should sell it. A 5 analysts rate it as either a buy or a strong buy, while1 believe that investors should either steer clear of RDUS or, if they already own its stock, sell it.

Is Viper Energy Partners LP (NASDAQ:VNOM) Cheap From Peers?

Viper Energy Partners LP (VNOM) pulled off a 1.51 percent gain and now trades for $15.43. VNOM comes in with a P/S ratio of 15.11 that’s greater than 1, potentially implying that it could be expensive relative to the overall sector (18.33) and its peers (125.06). Also, it has an estimated price-earnings (P/E) multiple of 13.09 and a trailing 12-month price-earnings (P/E) multiple of 44.47. During the last 52 weeks, the price has been as high as $19.38 and as low as $13.53. Viper Energy Partners LP (NASDAQ:VNOM) earnings have declined with a quarterly rate of 0% over the last 5 years. Shares of VNOM have sank -12.73% in the past three months, while the S&P 500 has dropped -19.13% in that time.

Viper Energy Partners LP (Price Objective: $20.79)

Viper Energy Partners LP (NASDAQ:VNOM) has a market cap of $1.49 billion and over the last 12 months, VNOM has declined by -17.13%. The average 1-year price target for (VNOM) reveals an average price target of $20.79 per share. That’s a potential 34.74 gain from where (NASDAQ:VNOM) has been trading recently. There are brokerage firms with lower targets than the average, including one setting a price target of $17. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $24.

Analyst Thoughts About Viper Energy Partners LP (NASDAQ:VNOM)

The consensus recommendation — averaging the work of 12 analysts — of 1.8 for Viper Energy Partners LP (VNOM) points to bullish case. Of the analysts surveyed by Reuters that track Viper Energy Partners LP 2 of them rate its stock a hold. The other 10 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. A 10 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NASDAQ:VNOM) or, if they already own its stock, sell it.